Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Oct-Dec;8(4):465-73.
doi: 10.1111/j.1582-4934.2004.tb00471.x.

Embryonic stem cells: a promising tool for cell replacement therapy

Michael Xavier Doss  1 , Christoph I Koehler, C Gissel, Jürgen Hescheler, Agapios Sachinidis
Affiliations
Review

Embryonic stem cells: a promising tool for cell replacement therapy

Michael Xavier Doss et al. J Cell Mol Med. 2004 Oct-Dec.

Abstract

Embryonic stem (ES) cells are revolutionizing the field of developmental biology as a potential tool to understand the molecular mechanisms occurring during the process of differentiation from the embryonic stage to the adult phenotype. ES cells harvested from the inner cell mass (ICM) of the early embryo can proliferate indefinitely in vitro while retaining the ability to differentiate into all somatic cells. Emerging results from mice models with ES cells are promising and raising tremendous hope among the scientific community for the ES-cell based cell replacement therapy (CRT) of various severe diseases. ES cells could potentially revolutionize medicine by providing an unlimited renewable source of cells capable of replacing or repairing tissues that have been damaged in almost all degenerative diseases such as diabetes, myocardial infarction and Parkinson's disease. This review updates the progress of ES cell research in CRT, discusses about the problems encountered in the practical utility of ES cells in CRT and evaluates how far this approach is successful experimentally.

PubMed Disclaimer

References

    1. Asahara T., Kalka C., Isner J.M., Stem cell therapy and gene transfer for regeneration, Gene Ther., 7: 451–457, 2000. - PubMed
    1. Fodor W. L., Tissue engineering and cell based therapies, from the bench to the clinic: the potential to replace, repair and regenerate, Reprod. Biol. Endocrinol. 1: 102, 2003. - PMC - PubMed
    1. Delcarpio J.B., Claycomb W.C., Cardiomyocyte transfer into the mammalian heart. Cell‐to‐cell interactions in vivo and in vitro , Ann. N. Y. Acad. Sci. 752: 267–285, 1995. - PubMed
    1. Koh G.Y., Soonpaa M.H., Klug M.G., Field L.J., Longterm survival of AT‐1 cardiomyocyte grafts in syngeneic myocardium, Am. J. Physiol. 264: H1727–H1733, 1993. - PubMed
    1. Koh G.Y., Soonpaa M.H., Klug M.G., Pride H.P., Cooper B.J., Zipes D.P., Field L.J., Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs, J. Clin. Invest. 96: 2034–2042, 1995. - PMC - PubMed